12 Einträge gefunden

1. Therapiealgorithmen für das Mammakarzinom

   1. Blohmer, Jens-Uwe
   2. Schneeweiss, Andreas
   3. Bauerfeind, I.
   4. Fehm, T
   5. Muller , Volkmar
   6. Thomssen, Christoph
   7. Witzel, Isabell

   2021 - Forschungsinformationssystem des UKE
2. Therapieoptionen beim hormonrezeptorpositiven, HER-2-negativen metastasierten Mammakarzinom

   1. Wöckel, Achim
   2. Bauerfeind, Ingo
   3. Fehm, Tanja
   4. Janni, Wolfgang
   5. Muller , Volkmar
   6. Thill, Marc
   7. Thomssen, Christoph

   2020 - Forschungsinformationssystem des UKE
3. ABC4-Konsensus: Bewertung durch eine deutsche Expertengruppe:4. Internationale Konsensuskonferenz zum fortgeschrittenen Mammakarzinom (ABC4), Lissabon, 04. 11. 2017

   1. Würstlein, Rachel
   2. Harbeck, Nadia
   3. Thomssen, Christoph
   4. Lüftner, Diana
   5. Augustin, Doris
   6. Briest, Susanne
   7. Ettl, Johannes

   2018 - Forschungsinformationssystem des UKE
4. Association between HER2, TOP2A, and response to anthracycline-based preoperative chemotherapy in high-risk primary breast cancer.

   1. Konecny, Gottfried E
   2. Pauletti, Giovanni
   3. Untch, Michael
   4. Wang, He-Jing
   5. Möbus, Volker
   6. Kuhn, Walther
   7. Thomssen, Christoph

   2010 - Forschungsinformationssystem des UKE
5. Reliability of human epidermal growth factor receptor 2 immunohistochemistry in breast core needle biopsies.

   1. Lebeau, Annette
   2. Turzynski, Andreas
   3. Braun, Susanne
   4. Behrhof, Wera
   5. Fleige, Barbara
   6. Schmitt, Wolfgang D
   7. Grob, Tobias

   2010 - Forschungsinformationssystem des UKE
6. Final results of a phase I/II pilot study of capecitabine with or without vinorelbine after sequential dose-dense epirubicin and paclitaxel in high-risk early breast cancer.

   1. Müller, Volkmar
   2. Thomssen, Christoph
   3. Schmidt, Marcus
   4. Glados, Manfred
   5. Jackisch, Christian
   6. Heilmann, Volker
   7. Hinke, Axel

   2010 - Forschungsinformationssystem des UKE - frei zugänglich
7. Intensive dose-dense compared with conventionally scheduled preoperative chemotherapy for high-risk primary breast cancer.

   1. Untch, Michael
   2. Möbus, Volker
   3. Kuhn, Walther
   4. Muck, Bernd Rudolph
   5. Thomssen, Christoph
   6. Bauerfeind, Ingo
   7. Harbeck, Nadia

   2009 - Forschungsinformationssystem des UKE
8. Feasibility of measuring the prognostic factors uPA and PAI-1 in core needle biopsy breast cancer specimens.

   1. Thomssen, Christoph
   2. Harbeck, Nadia
   3. Dittmer, Juergen
   4. Abraha-Spaeth, Shanti R
   5. Papendick, Nancy
   6. Paradiso, Angelo
   7. Lisboa, Bjoern

   2009 - Forschungsinformationssystem des UKE
9. A comparative study of tissue inhibitor of metalloproteinases-1 levels in plasma and tumour tissue from patients with primary breast cancer and in plasma from patients with metastatic breast cancer.

   1. Schrohl, Anne-Sofie
   2. Müller, Volkmar
   3. Christensen, Ib Jarle
   4. Pantel, Klaus
   5. Thomssen, Christoph
   6. Bruenner, Nils

   2008 - Forschungsinformationssystem des UKE
10. DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients--Technical and clinical validation in a multi-centre setting in collaboration with the European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology group.

    1. Maier, Sabine
    2. Nimmrich, Inko
    3. Koenig, Thomas
    4. Eppenberger-Castori, Serenella
    5. Bohlmann, Inga
    6. Paradiso, Angelo
    7. Spyratos, Frédérique

    2007 - Forschungsinformationssystem des UKE
11. Cyclooxygenase-2 is a target gene of rho GDP dissociation inhibitor beta in breast cancer cells.

    1. Schunke, Dario
    2. Span, Paul
    3. Ronneburg, Henrike
    4. Dittmer, Angela
    5. Vetter, Martina
    6. Holzhausen, Hans-Jürgen
    7. Kantelhardt, Eva

    2007 - Forschungsinformationssystem des UKE
12. Prognostic and predictive impact of soluble epidermal growth factor receptor (sEGFR) protein in the serum of patients treated with chemotherapy for metastatic breast cancer.

    1. Müller, Volkmar
    2. Witzel, Isabell
    3. Pantel, Klaus
    4. Krenkel, Sylke
    5. Lück, Hans Joachim
    6. Neumann, Rainer
    7. Keller, Thomas

    2006 - Forschungsinformationssystem des UKE